ClinConnect ClinConnect Logo
Search / Trial NCT05073952

Keratized Mucosa in CG Implant Placement: CTG vs Flapless

Launched by UNIVERSITY OF MILAN · Oct 11, 2021

Trial Information

Current as of July 04, 2025

Recruiting

Keywords

Dental Implant Keratinized Mucosa Connective Tissue Graft Flapless Implant Placement Computer Guided Implantology Immediate Loading

ClinConnect Summary

This clinical trial is exploring two different methods of placing dental implants in patients who have lost teeth in the back of their mouth. The study aims to find out how the amount of keratinized mucosa (a type of tissue that covers the gums) differs between a flapless approach, where the gum is not cut open, and a flap surgery approach, which uses a connective tissue graft. This research is important because having enough keratinized mucosa can help improve the health and stability of dental implants.

To participate in this trial, you need to be at least 18 years old and have lost some teeth in the back of your mouth for at least three months. You also need to have enough bone for the implant to be placed without needing any additional procedures. Participants will receive detailed information about the study and need to agree to join. If you have certain health issues or conditions, such as severe bleeding disorders or are pregnant, you may not be eligible. Throughout the study, participants can expect close monitoring and care to ensure their well-being during the implant placement process.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 18+
  • Patients with partial edentulism in the posterior region (4-7) upper or lower for at least 3 months
  • Patient whose tomographic examination shows adequate bone volumes for computer guided placement of a standard diameter implant (\> 3.5 mm) without the need for bone regeneration procedures
  • Patients who have accepted informed consent and participation in the study
  • Patients who do not have exclusion criteria
  • Eclusion Criteria
  • Patients who refuse to co-operate
  • * Systemic conditions of exclusion:
  • Medical conditions requiring prolonged use of steroids
  • Severe hemophilia
  • In therapy with intravenous bisphosphonates
  • History of white blood cell dysfunction or deficiency
  • History of head and neck radiotherapy or chemotherapy
  • History of kidney failure
  • Pregnant or breastfeeding patient
  • History of uncontrolled endocrine disorders
  • Physical handicaps that hinder proper oral hygiene
  • Use of experimental devices or drugs within 30 days prior to implant placement surgery
  • Alcoholism or drug abuse
  • Smokers of\> 10 cigarettes per day or the equivalent cigar or\> 10 tobacco-based chewings per day
  • Conditions or circumstances that prevent the completion of participation in the study or interfere with the analysis of the study results
  • Local exclusion conditions:
  • Local inflammation, including untreated periodontitis
  • Patients with erosive lichen planus
  • History of local radiation therapy
  • Presence of bone lesions
  • Unhealed extraction sites
  • History of bone reconstruction and bone grafting techniques in the sites where the implants are to be inserted
  • Bruxism
  • Bleeding index\> 30% and number of pockets\> 5mm greater than 10

About University Of Milan

The University of Milan is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes and fostering innovation in medical science. Its research initiatives are guided by a dedication to ethical standards and rigorous scientific methodologies, ensuring that trials not only contribute to the body of knowledge but also prioritize patient safety and well-being. Through its extensive network of researchers and clinicians, the University of Milan plays a pivotal role in translating scientific discoveries into practical applications that benefit communities both locally and globally.

Locations

Milan, Mi, Italy

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials